Prestige Wealth Management Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$45.7K Sell
87
-3
-3% -$1.58K 0.01% 263
2025
Q1
$57.1K Sell
90
-11
-11% -$6.98K 0.01% 235
2024
Q4
$71.9K Buy
101
+19
+23% +$13.5K 0.02% 225
2024
Q3
$86.2K Sell
82
-20
-20% -$21K 0.02% 204
2024
Q2
$107K Sell
102
-49
-32% -$51.5K 0.02% 172
2024
Q1
$145K Sell
151
-16
-10% -$15.4K 0.03% 172
2023
Q4
$147K Sell
167
-5
-3% -$4.39K 0.03% 154
2023
Q3
$142K Buy
172
+3
+2% +$2.47K 0.03% 156
2023
Q2
$121K Sell
169
-292
-63% -$210K 0.03% 187
2023
Q1
$379K Buy
461
+293
+174% +$241K 0.1% 100
2022
Q4
$121K Sell
168
-11
-6% -$7.94K 0.03% 172
2022
Q3
$124K Sell
179
-2
-1% -$1.39K 0.03% 159
2022
Q2
$107K Buy
181
+6
+3% +$3.55K 0.03% 171
2022
Q1
$122K Sell
175
-293
-63% -$204K 0.03% 173
2021
Q4
$295K Buy
468
+118
+34% +$74.4K 0.07% 113
2021
Q3
$212K Buy
350
+219
+167% +$133K 0.05% 132
2021
Q2
$73K Sell
131
-4
-3% -$2.23K 0.02% 207
2021
Q1
$64K Buy
135
+42
+45% +$19.9K 0.02% 225
2020
Q4
$45K Sell
93
-88
-49% -$42.6K 0.01% 259
2020
Q3
$101K Buy
181
+32
+21% +$17.9K 0.03% 173
2020
Q2
$93K Buy
149
+99
+198% +$61.8K 0.03% 159
2020
Q1
$24K Hold
50
0.01% 256
2019
Q4
$19K Hold
50
0.01% 299
2019
Q3
$14K Hold
50
0.01% 313
2019
Q2
$16K Hold
50
0.01% 293
2019
Q1
$21K Sell
50
-34
-40% -$14.3K 0.01% 274
2018
Q4
$31K Buy
+84
New +$31K 0.02% 246